ELR+ CXC chemokine expression in benign and malignant colorectal conditions
2008

Chemokine Expression in Colorectal Conditions

Sample size: 94 publication 10 minutes Evidence: high

Author Information

Author(s): Rubie Claudia, Frick Vilma Oliveira, Wagner Mathias, Schuld Jochen, Gräber Stefan, Brittner Brigitte, Bohle Rainer M, Schilling Martin K

Primary Institution: University of the Saarland

Hypothesis

The study investigates the expression profiles of CXCL1, CXCL5, and CXCL6 in colorectal adenoma and carcinoma to understand their role in cancer progression.

Conclusion

The study found that CXCL1 and CXCL5 are significantly associated with the progression from colorectal adenoma to carcinoma.

Supporting Evidence

  • CXCL1 and CXCL5 were significantly up-regulated in CRC and CRLM tissues compared to matched normal tissues.
  • CXCL5 showed a much more pronounced overexpression in CRC tissues compared to CXCL1.
  • The study indicates a progressive increase in chemokine expression from premalignant conditions to malignancy.

Takeaway

This study looked at how certain proteins related to inflammation and cancer are more present in people with colorectal cancer compared to those with benign conditions.

Methodology

The study used microdissection, quantitative real-time PCR, ELISA, and immunohistochemistry to assess chemokine expression.

Participant Demographics

{"total_participants":94,"gender_distribution":{"male":46,"female":32},"age_range":"41-78"}

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-8-178

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication